Hripsime Avagyan, Ben Goldenson, Eric Tse, Ava Masoumi, Verna Porter, Martina Wiedau-Pazos, James Sayre, Reno Ong, Michelle Mahanian, Patrick Koo, Susan Bae, Miodrag Micic, Philip T Liu, Mark J Rosenthal, Milan Fiala
Alzheimer disease (AD) patients have an impairment of anti-amyloid-beta (Abeta) innate immunity and a defect in immune gene transcription [Fiala, M., Liu, P.T., Espinosa-Jeffrey, A., Rosenthal, M.J., Bernard, G., Ringman, J.M., Sayre, J., Zhang, L., Zaghi, J., Dejbakhsh, S., Chiang, B., Hui, J., Mahanian, M., Baghaee, A., Hong, P., Cashman, J., 2007b. Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin. Proc. Natl. Acad. Sci...
May 29, 2009: Journal of Neuroimmunology